Skip to main content
SpringerLink
Log in

PREAMI: Perindopril and Remodelling in Elderly with Acute Myocardial Infarction: Study Rationale and Design

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Angiotensin-converting enzyme (ACE) inhibitors reduce mortality, the development of remodeling, left ventricular (LV) dysfunction, and ischemic events, both when administered alone as long-term treatment in patients with impaired LV function and/or heart failure (HF) and as short-term treatment, early after acute myocardial infarction (AMI) and/or HF. The few data available on the use of ACE inhibitors in the elderly after AMI are conflicting. Nothing is known about the effects of ACE inhibitors in elderly postinfarction patients with preserved LV function: these patients have a remarkable medium- to long-term mortality and HF incidence after infarction. The aim of this study is to evaluate, in patients with AMI aged ≥65 years, the effects of Perindopril on the combined outcome of death, hospitalization for HF, and heart remodeling, considered to be a ≥8% increase in LV end-diastolic volume (LVEDV). Secondary objectives include the same factors listed in the primary end points but considered separately. In addition, safety of the drug, ventricular remodeling, and adaptation are being evaluated. A total of 1100 patients with AMI (first episode or reinfarction), aged ≥65 years, and preserved or only moderately depressed LV (LV ejection fraction ≥40%), are to be enrolled and randomly assigned to treatment (8 mg for 12 months of Perindopril or placebo, in double-blind conditions). Clinical assessment is performed at fixed times, and periodic evaluations of (1) ventricular shape, dimensions, and function by quantitative 2-D echocardiography, and (2) heart rate variability and arrhythmias by ambulatory electrocardiographic monitoring are anticipated. The results and conclusions will be available by 2002 year.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Braunwald E. ACE-inhibitors. A cornerstone of the treatment of heart failure. N Engl J Med 1991;325:351-353.

    PubMed  Google Scholar 

  2. Unger T, Gohlke P. Converting enzyme inhibitors in cardiovascular therapy: Current status and future potential. Cardiovasc Res 1994;28:146-158.

    PubMed  Google Scholar 

  3. The SOLVD Investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.

    Google Scholar 

  4. Pfeffer MA, Braunwald E, Moye IA, et al. On behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-677.

    PubMed  Google Scholar 

  5. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-828.

    Google Scholar 

  6. Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333:1670-1676.

    Google Scholar 

  7. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. GISSI-3. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-1122.

    Google Scholar 

  8. ISIS-4. A randomised factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.

    Google Scholar 

  9. 1999 Update: ACC/AHA Guidelines for the Management of Patients with Acute Myocardial Infarction: Executive Summary and Recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999;100:1016-1030.

  10. Pitt B. ACE inhibitor use in elderly patients with systolic left ventricular dysfunction: Problems and opportunities. Br J Clin Pract Suppl 1996;84:11-16.

    PubMed  Google Scholar 

  11. Flather MD, Yusuf S, Kober L, et al. Long-term ACEinhibitor therapy in patients with heart failure or leftventricular dysfunction:Asystematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-1581.

    PubMed  Google Scholar 

  12. Maggioni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E, Tognoni G. On behalf of the Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. N Engl J Med 1993;329:1442-1448.

    PubMed  Google Scholar 

  13. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community. A study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998;98:2282-2289.

    PubMed  Google Scholar 

  14. Diller PM, Smucker DR, David B, Graham RJ. Congestive heart failure due to diastolic or systolic dysfunction. Frequency and patient characteristics in an ambulatory setting. Arch Fam Med 1999;8:414-420.

    PubMed  Google Scholar 

  15. Schweiger C, De Vita C, Langiano T. EARISA Studio sulla epidemiologia e sull'assorbimento di risorse di ischemia, scompenso e aritmie. G It Cardiol 1997;27(Suppl. 2):1-54.

    Google Scholar 

  16. Holmes DR, White HD, Pieper HKS, Ellis SG, Califf RM, Topol EJ. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am Coll Cardiol 1991;33:412-419.

    Google Scholar 

  17. Latini R, Nicolosi G, Maggioni AP, Franzosi MG, Barlera S, Masson S. On behalf of the GISSI-3 Investigators. The beneficial effect of lisinopril on left ventricular remodeling after a first myocardial infarction is modulated by age. The GISSI-3 echo database. J Am Coll Cardiol 1996;27(Suppl. A):281A.

    Google Scholar 

  18. Remme WJ, Bartels GL. Anti-ischaemic effects of converting enzyme inhibitors: Underlying mechanisms and future prospects. Eur Heart J 1995;16(Suppl. I):87-95.

    Google Scholar 

  19. Asmar RG, Pannier B, Santoni JP, et al. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 1988;78:941-950.

    PubMed  Google Scholar 

  20. Sihm I, Schroeder AP, Aalkjaer C, et al. Normalization of cardiovascular structure during antihypertensive treatment with a regimen based on the ACE-inhibitor Perindopril. Blood Pressure 1995;4:241-248.

    PubMed  Google Scholar 

  21. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25:474-481.

    PubMed  Google Scholar 

  22. Antony I, Lerebours G, Nitenberg A. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients. Circulation 1996;94:3115-3122.

    PubMed  Google Scholar 

  23. Drexler H, Kurs S, Jeserich M, Münzel T, Hornig B. Effects of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure. Am J Cardiol 1995;76:13E-18E.

    PubMed  Google Scholar 

  24. Bartels GL, van-don-Heuvel FM, van-Veldhuisen DJ, van-der Ent M, Remme WJ. Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function. Am J Cardiol 1999;83:332-336.

    PubMed  Google Scholar 

  25. Zeitz CJ, Campbell J, Pelle MA, Ninio DM, Horowitz JD. Perindoprilat improves coronary vasodilator reserve during induction of myocardial ischemia. Circulation 1998;98:I-2566.

    Google Scholar 

  26. Bonaduce D, Marciano F, Petretta M, et al. Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation 1994;90:108-113.

    PubMed  Google Scholar 

  27. Dambrink JH, Tuininga YS, van Gilst WH, Peels KH, Lie KI, Kingma JH. Association between reduced heart rate variability and left ventricular dilatation in patients with a first anterior myocardial infarction. CATS Investigators. Captopril and Thrombolysis Study. Br Heart J 1994;72:514-520.

    PubMed  Google Scholar 

  28. Molnar J, Weiss J, Zhang F, Rosenthal JE. Evaluation of five QT correction formulas using a software-assisted method of continuous QT measurement from 24-hour Holter recordings. Am J Cardiol 1996;78:920-926.

    PubMed  Google Scholar 

  29. Degaute JP, Leeman M, Desche P. Long-term acceptability of Perindopril: European multicentre trial on 856 patients. Am J Med 1992;92(Suppl. 4B):84S-90S.

    Google Scholar 

  30. MacFayden RJ, Lees KR, Reid JL. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: A placebo controlled study. Br Heart J 1991;66:206-211.

    PubMed  Google Scholar 

  31. Lau C, Tse HF, Ng W, et al. Are different angiotensin converting enzyme inhibitors identical for treatment of acute myocardial infarction? Results from the Hong-Kong postmyocardial infarction trial (abstr). Eur Heart J 1999;20:287.

    Google Scholar 

  32. Suraniti S, Berrut G, Marre M, Fressinaud P. Antihypertensive efficacy and acceptability of Perindopril in elderly hypertensive patients. Am J Cardiol 1993;71:28E-31E.

    PubMed  Google Scholar 

  33. Dyker AG, Grosset DG, Less KR. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. Stroke 1997;28:580-583.

    PubMed  Google Scholar 

  34. Manche A, Galea J, Busuttil W. Tolerance to ACE inhibitors after cardiac surgery. Eur J Cardiothorac Surg 1999;15:55-60.

    PubMed  Google Scholar 

  35. Nicolosi GL, Latini R, Marino P, et al. The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 trial. Eur Heart J 1996;17:1646-1656.

    PubMed  Google Scholar 

  36. Freeman LS. Tables of the number of patients required in clinical trials using the Logrank test. Stat Med 1982;1:121-129.

    PubMed  Google Scholar 

  37. Kaplan-Meier. Nonparametric estimation from incomplete observations. J Am Stat Asso 1959;53:475-481.

    Google Scholar 

  38. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977;35:1-39.

    PubMed  Google Scholar 

  39. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.

    Google Scholar 

  40. Morrison DF, ed. Multivariate Statistical Methods, New York: McGraw-Hill, 1976.

    Google Scholar 

  41. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of diseases. J Natl Cancer Inst 1959;22:719-748.

    PubMed  Google Scholar 

  42. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocard 1989;2:358-367.

    Google Scholar 

  43. Maestri R, Pinna GD. POLYAN: A computer program for polyparametric analysis of cardio-respiratory variability signals. Comp Meth Progr Biomed 1998;56:37-48.

    Google Scholar 

  44. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurements, physiological interpretation and clinical use. Circulation 1996;93:1043-1065.

    Google Scholar 

  45. Pinna GD, Maestri R, Di Cesare A. Application of time series spectral analysis theory: Analysis of cardiovascular variability signals. Med Biol Eng Comput 1996;34:142-148.

    PubMed  Google Scholar 

  46. Stramba-Badiale M, Locati EH, Martinelli A, Courville J, Schwartz PJ. Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recording. Eur Heart J 1997;18:1000-1006.

    PubMed  Google Scholar 

Download references

Authors
  1. The PREAMI Investigators
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

The PREAMI Investigators PREAMI: Perindopril and Remodelling in Elderly with Acute Myocardial Infarction: Study Rationale and Design. Cardiovasc Drugs Ther 14, 671–679 (2000). https://doi.org/10.1023/A:1007879201470

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007879201470

Search

Navigation